Showing results (71-80 of 97) with videos related to

Sort By:
Pageof 10
Chinese Journal of Cancer|September 16, 2015
Autologous peripheral blood stem cell mobilization following dose-adjusted cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy alone or in combination with rituximab in treating high-risk non-Hodgkin's lymphomaYuankai Shi, Ping Zhou, Xiaohong Han, et al.
Annals of Hematology|October 20, 2023
Development and validation of a novel risk stratification model and a survival rate calculator for diffuse large B-cell lymphoma in the rituximab era: a multi-institutional cohort studyQiaofeng Zhong, Haizhu Chen, Daoguang Chen, et al.
Journal of Translational Medicine|October 11, 2019
Tracking longitudinal genetic changes of circulating tumor DNA (ctDNA) in advanced Lung adenocarcinoma treated with chemotherapyXiaohong Han, Ying Han, Qiaoyun Tan, et al.
Zhonghua Yi Xue Za Zhi|April 29, 2016
[Clinicopathological characteristics and prognostic analysis of primary intestinal diffuse large B-cell lymphoma]Yu Huang, Shengyu Zhou, Xiaohui He, et al.
International Journal of Clinical Practice|June 10, 2022
Micronutrient Level Is Negatively Correlated with the Neutrophil-Lymphocyte Ratio in Patients with Severe COVID-19Shengyu Zhou, Fayan Zhang, Fangfang Chen, et al.
Leukemia & Lymphoma|July 13, 2019
Upfront radiation is essential for high-risk early-stage extranodal NK/T-cell lymphoma, nasal type: comparison of two sequential treatment modalities combining radiotherapy and GDP (gemcitabine, dexamethasone, and cisplatin) in the modern eraFei Qi, Bo Chen, Jingjing Wang, et al.
Redox Biology|April 30, 2024
Development and translation of thiometallate sulfide donors using a porcine model of coronary occlusion and reperfusionThomas W Johnson, James Holt, Anna Kleyman, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|April 19, 2019
Clinical features and outcomes of diffuse large B-cell lymphoma based on nodal or extranodal primary sites of origin: Analysis of 1,085 WHO classified cases in a single institution in ChinaYuankai Shi, Ying Han, Jianliang Yang, et al.
Chronic Diseases and Translational Medicine|September 10, 2021
Recombinant human thrombopoietin prior to mobilization chemotherapy facilitates platelet recovery in autologous transplantation in patients with lymphoma: Results of a prospective randomized studyHongnan Mo, Peng Liu, Yan Qin, et al.
Asia-Pacific Journal of Clinical Oncology|January 20, 2017
Comparison of CBV, BEAM and BEAC high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation in non-Hodgkin lymphoma: Efficacy and toxicityYouwu Shi, Peng Liu, Shengyu Zhou, et al.
Pageof 10